Quantum量子訊息有限公司

Transdermal Medical Patch Market

完整報告名稱與涵蓋範圍
Transdermal Medical Patch Market Size, Share & Trends Analysis Report By Type (Single Drug-in-Adhesive, Multi-layer Drug-in Adhesive, Reservoir, Vapor Patch, Matrix), By Application, By Distribution Channel, By Region, And By Segment Forecasts, 2025-2034

報告摘要

The worldwide Transdermal Medical Patch Market stood at USD 8.2 Bn in 2024, and is anticipated to reach USD 13.1 Bn by 2034, recording a CAGR of 4.9% from 2025 through 2034. The Transdermal Medical Patch sector involves sticky patches that, when put on the skin, release a set amount of medicine into the body. This domain has witnessed meaningful transformation owing to technological breakthroughs and shifting healthcare dynamics. Market momentum is supported by growing appetite for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies. Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential. Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region anticipated to deliver the strongest growth trajectory through the forecast period, supported by demographic shifts and policy support. The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion. The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.

授權報價

Single User PDF$4,500 USD
Global Site License PDF$9,500 USD

目錄 Table of Contents

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Transdermal Medical Patch Market Snapshot Chapter 4. Global Transdermal Medical Patch Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. Competitive Landscape & Market Share Analysis 4.8. Impact of Covid-19 Analysis Chapter 5. Market Segmentation 1: By Type Estimates & Trend Analysis 5.1. By Type, & Market Share, 2024-2034 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following By Type: 5.2.1. Single Layer Drug-in-Adhesive 5.2.2. Multi-layer Drug-in-Adhesive 5.2.3. Reservoir 5.2.4. Vapor Patch 5.2.5. Matrix Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis 6.1. By Application & Market Share, 2024-2034 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following By Application: 6.2.1. Neurologic Conditions 6.2.2. Pain Management 6.2.3. Nicotine Cessation 6.2.4. Cardiovascular Disorders 6.2.5. Hormonal Therapy 6.2.6. Others Chapter 7. Market Segmentation 3: By Distribution Channel Estimates & Trend Analysis 7.1. By Distribution Channel & Market Share, 2024-2034 7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following By Distribution Channel: 7.2.1. Hospital Pharmacies 7.2.2. Retail Pharmacies 7.2.3. Online Pharmacies Chapter 8. Transdermal Medical Patch Market Segmentation 4: Regional Estimates & Trend Analysis 8.1. North America 8.1.1. North America Transdermal Medical Patch Market revenue (US$ Million) estimates and forecasts By Type, 2021-2034 8.1.2. North America Transdermal Medical Patch Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034 8.1.3. North America Transdermal Medical Patch Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2021-2034 8.1.4. North America Transdermal Medical Patch Market revenue (US$ Million) estimates and forecasts by country, 2021-2034 8.2. Europe 8.2.1. Europe Transdermal Medical Patch Market revenue (US$ Million) By Type, 2021-2034 8.2.2. Europe Transdermal Medical Patch Market revenue (US$ Million) By Application, 2021-2034 8.2.3. Europe Transdermal Medical Patch Market revenue (US$ Million) By Distribution Channel, 2021-2034 8.2.4. Europe Transdermal Medical Patch Market revenue (US$ Million) by country, 2021-2034 8.3. Asia Pacific 8.3.1. Asia Pacific Transdermal Medical Patch Market revenue (US$ Million) By Type, 2021-2034 8.3.2. Asia Pacific Transdermal Medical Patch Market revenue (US$ Million) By Application, 2021-2034 8.3.3. Asia Pacific Transdermal Medical Patch Market revenue (US$ Million) By Distribution Channel, 2021-2034 8.3.4. Asia Pacific Transdermal Medical Patch Market revenue (US$ Million) by country, 2021-2034 8.4. Latin America 8.4.1. Latin America Transdermal Medical Patch Market revenue (US$ Million) By Type, (US$ Million) 2021-2034 8.4.2. Latin America Transdermal Medical Patch Market revenue (US$ Million) By Application, (US$ Million) 2021-2034 8.4.3. Latin America Transdermal Medical Patch Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2021-2034 8.4.4. Latin America Transdermal Medical Patch Market revenue (US$ Million) by country, 2021-2034 8.5. Middle East & Africa 8.5.1. Middle East & Africa Transdermal Medical Patch Market revenue (US$ Million) By Type, (US$ Million) 2021-2034 8.5.2. Middle East & Africa Transdermal Medical Patch Market revenue (US$ Million) By Application, (US$ Million) 2021-2034 8.5.3. Middle East & Africa Transdermal Medical Patch Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2021-2034 8.5.4. Middle East & Africa Transdermal Medical Patch Market revenue (US$ Million) by country, 2021-2034 Chapter 9. Competitive Landscape 9.1. Major Mergers and Acquisitions/Strategic Alliances 9.2. Company Profiles 9.2.1. Hisamitsu Pharmaceutical co inc 9.2.2. Medline Industries LP 9.2.3. Johnson & Johnson 9.2.4. Novartis AG 9.2.5. Teva Pharmaceutical Industries Ltd 9.2.6. UCB SA 9.2.7. Viatris Inc 9.2.8. Endo Pharmaceutical Inc 9.2.9. Boehringer ingelheim international GmbH 9.2.10. Corium LLC 9.2.11. Luye Pharma Group 9.2.12. Teikoku Pharma 9.2.13. Samyang Holdings Corporation 9.2.14. Gedeon Richter PLC 9.2.15. AdhexPharma 9.2.16. Sparsha Pharma International Pvt Ltd.

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們